References
- MacMahon S., Peto R., Cutler J., Collins R., Sorlie P., Neaton J., et al. Blood pressure, stroke, and coronary heart disease. Part 1. prolonged differences in blood pressure: prospective observational studies corrected for the regression dilution bias. Lancet 1990; 335: 765
- Kannel WB. Office assessment of coronary candidates and risk factor insights from the Framingham Study. J Hypert 1991; 9: S13–S19, (Suppl 7)
- Alderman MH. Blood pressure management: individual treatment based on absolute risk and the potential of benefit. Ann Intern Med 1993; 119: 329–335
- Alderman M. H., Cohen H., Madhavan S. Distribution and determinants of cardiovascular events during 20 years of successful antihypertensive treatment. J Hypert 1998; 16: 761–769
- Alderman M. H., Madhavan S., Cohen H. Antihypertensive drug therapy: the effect of JNC criteria on prescribing patterns and patient status through the first year. Am J Hypert 1996; 9(5)413–418
- Ward HJ. Uric acid as an independent risk factor in the treatment of hypertension. Lancet 1998; 352: 670–671
- Alderman M. H., Madhavan S., Ooi W. L., Sealey J., Laragh JH. Association of the renin-sodium profile with the risk of myocardial infarction in patients with hypertension. N Engl J Med 1991; 324(16)1098–1104
- Alderman M. H., Ooi W. L., Cohen H., Madhavan S., Sealey J. E., Laragh JH. Plasma renin activity: a risk factor for myocardial infarction in hypertensive patients. Am J Hypert 1997; 10(1)1–8